(Q42472922)

1 November 2017

title

Platelet serotonin, plasma cortisol, and dexamethasone suppression test in schizophrenic patients (English)

1 reference

dexamethasone suppression test

1 November 2017

0 references

0 references

0 references

0 references

1 reference

2

1 reference

1 November 2017

Mück-Seler D

1

1 reference

1 November 2017

Jakovljević M

series ordinal

3

1 reference

1 November 2017

Brzović Z

series ordinal

4

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

1 November 2017

published in

Biological Psychiatry

1 reference

1 November 2017

volume

45

1 reference

1 November 2017

issue

11

1 reference

1 November 2017

page(s)

1433-1439

1 reference

The role of serotonin in the pathophysiology and treatment of schizophrenia

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Human brain cortex and platelet serotonin2 receptor binding properties and their regulation by endogenous serotonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Serotonin uptake by blood platelets of schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

The Dexamethasone Suppression Test in depression, in schizophrenia, and during experimental stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Serial dexamethasone suppression tests in psychiatric illness: Part I. A study in schizophrenia and mania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Serial dexamethasone suppression tests in psychiatric illness: Part III. The influence of intervening variables

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Blood serotonin levels in suicidal schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Serotonin, schizophrenia and antipsychotic drug action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Physiopharmacological interactions between stress hormones and central serotonergic systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Increased whole blood serotonin concentrations in chronic schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Are schizophrenics with abnormal dexamethasone suppression test results a distinct subgroup?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Serotonin and the regulation of hypothalamic-pituitary-adrenal axis function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Effects of diagnosis, laterality, and gender on brain morphology in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

The role of serotonin in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Seasonal influence on platelet 5-HT levels in patients with recurrent major depression and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Dexamethasone suppression test in schizophrenia: its relation to monoamine metabolism in hypothalamic-pituitary-adrenal axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Age and the dexamethasone suppression test: results from a broad unselected patient population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Platelet serotonin concentration in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Changes induced by corticosterone and adrenalectomy in synaptosomal and platelet uptake and binding of 5-HT. The relationship to [3H]imipramine binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Time course of schizophrenia and platelet 5-HT level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Platelet serotonin in subtypes of schizophrenia and unipolar depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Effect of age on platelet 5-HT concentrations in healthy controls, depressed and schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Platelet 5-HT levels and hypothalamic-pituitary-adrenal axis activity in schizophrenic patients with positive and negative symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Serotonin transporter expression in rat brain regions and blood platelets: aging and glucocorticoid effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Dexamethasone suppression test and noradrenergic function in affective and schizophrenic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

The potential role of excessive cortisol induced by HPA hyperfunction in the pathogenesis of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Positive and negative symptoms in schizophrenia and the Dexamethasone Suppression Test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

Dexamethasone suppression test in schizophrenia: Relationship to symptomatology, ventricular enlargement, and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900174-7

10.1016/S0006-3223(98)00174-7

7 January 2021

Identifiers

DOI

1 reference

1 November 2017

1 reference